
Tirzepatide
A synthetic, lipid-modified peptide identified in the literature as LY3298176, with GIP and GLP-1 receptor activity in laboratory assays.
17 compounds and blends. 25 individually labeled vial sizes. Exclusively for laboratory research.
17 products

A synthetic, lipid-modified peptide identified in the literature as LY3298176, with GIP and GLP-1 receptor activity in laboratory assays.

A synthetic peptide also designated LY3437943, studied in laboratory assays involving GIP, GLP-1 and glucagon receptors.




A two-component preparation labeled 5 mg CJC-1295 and 5 mg ipamorelin. The exact CJC form awaits supplier documentation.

A synthetic peptide analog of growth-hormone-releasing hormone, with a modified amino terminus.

A synthetic 29-residue peptide corresponding to the amino-terminal region of growth-hormone-releasing hormone.





A synthetic cyclic peptide identified by the Melanotan II designation, distinct from linear melanocortin analogs.




Please confirm your age to view product details.
